Correlation Between Edgewise Therapeutics and Vaccibody
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Vaccibody at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Vaccibody into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Vaccibody As, you can compare the effects of market volatilities on Edgewise Therapeutics and Vaccibody and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Vaccibody. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Vaccibody.
Diversification Opportunities for Edgewise Therapeutics and Vaccibody
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Edgewise and Vaccibody is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Vaccibody As in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaccibody As and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Vaccibody. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaccibody As has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Vaccibody go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Vaccibody
If you would invest 223.00 in Vaccibody As on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Vaccibody As or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 4.76% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Vaccibody As
Performance |
| Timeline |
| Edgewise Therapeutics |
| Vaccibody As |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Edgewise Therapeutics and Vaccibody Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Vaccibody
The main advantage of trading using opposite Edgewise Therapeutics and Vaccibody positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Vaccibody can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaccibody will offset losses from the drop in Vaccibody's long position.| Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
| Vaccibody vs. Molecular Partners AG | Vaccibody vs. MediciNova | Vaccibody vs. Anebulo Pharmaceuticals | Vaccibody vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |